Buy Satsuma Pharmaceuticals Inc Stock | STSA Stock Price & Latest News | Public
STSA

Satsuma Pharmaceuticals Inc

$0.00 (0.00%)Today

    About STSA

    Satsuma Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company. It develops novel therapeutic products for the acute treatment of migraine. The company was founded by John Kollins on June 21, 2016 and is headquartered in San Francisco, CA. The full company ...Read more

    Buy any stock with any amount of money.

    Download the App
    Download the app

    What Wall Street Thinks

    Events

    List of events that could affect this stock.

    Earnings

    The value each share was expected to gain vs. the value that each share actually gained

    0
    -0.23
    -0.46
    -0.69
    Q1 2020
    Q2 2020
    Q3 2020
    Q4 2020

    Expected EPS
    Q4 2020

    -$0.45

    Actual EPS
    Q4 2020

    Stats

    Market Cap$81,53M
    Volume7,44k
    Price-to-Earnings Ratio
    Dividend Rate
    Dividend Yield
    1 Year High$36.10
    1 Year Low$3.50
    Open$4.56
    High$4.63
    Low$4.38

    Buy any stock with any amount of money.

    Download the App
    Download the app